| 1) |
Principles of Prenatal Screening: Mark Evans, MD |
 |
| 2) |
1st and 2nd Trimester Chemistry, Where is it heading? Philip Buchanan, PhD |
|
| 3) |
OSCAR-Clinical Implementation: Jo-Ann Johnson, MD |
|
| 4) |
Integrated Screening: Philip Wyatt, MD, PhD |
|
| 5) |
Contingency Screening: Howard Cuckle, PhD
|
|
| 6) |
Cross Trimester Marker Ratio: David Wright, PhD |
|
| 7) |
European Approach: Francoise Muller, MD |
|
| 8) |
The Canadian Experience: Jo-Ann Johnson/Philip Wyatt, MD, PhD |
|
| 9) |
Placental and Other Markers on Adverse Outcomes: Francois Audibert, MD |
|
| 10) |
Closing Remarks: Philip Wyatt, MD, PhD |
|